ARTICLE | Financial News
Moleculin Biotech amends IPO
May 9, 2016 7:00 AM UTC
Moleculin Biotech Inc., Houston, Texas Business: Cancer Date announced: 2016-05-02 Type: IPO To be raised: Up to $12 million Shares: 2 million Price: $6 Underwriters: Bonwick Capital Partners; Network...